Payment overview · 2025
General Payments
$34.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Danna K Stuart, MD
Allopathic & Osteopathic Physicians|Family Medicine · SHATTUCK, OK · NPI 1891716775
Verified facts
What the public records show
CMS Open Payments records show Danna K Stuart, MD received $34.00 in general payments during 2025 across 1 reported records.
ABBVIE INC. accounted for 100.0% of that reported general-payment amount.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $34.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 496 | 97 |
| Atorvastatin Calcium | Atorvastatin Calcium | 427 | 95 |
| Lisinopril | Lisinopril | 427 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 331 | 86 |
| Furosemide | Furosemide | 298 | 70 |
| Potassium Chloride | Potassium Chloride | 282 | 53 |
| Sertraline Hcl | Sertraline Hcl | 229 | 42 |
| Hydrochlorothiazide | Hydrochlorothiazide | 215 | 49 |
| Gabapentin | Gabapentin | 195 | 44 |
| Losartan Potassium | Losartan Potassium | 194 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 170 | 35 |
| Trazodone Hcl | Trazodone Hcl | 162 | 29 |
| Omeprazole | Omeprazole | 160 | 39 |
| Montelukast Sodium | Montelukast Sodium | 159 | 39 |
| Simvastatin | Simvastatin | 155 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 146 | 28 |
| Tamsulosin Hcl | Tamsulosin Hcl | 143 | 27 |
| Pantoprazole Sodium | Pantoprazole Sodium | 139 | 31 |
| Warfarin Sodium | Warfarin Sodium | 132 | suppressed |
| Carvedilol | Carvedilol | 122 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 99 | 29 |
| Donepezil Hcl | Donepezil Hcl | 95 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 93 | 29 |
| Meloxicam | Meloxicam | 88 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 87 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 84 | 26 |
| Glipizide | Glipizide | 84 | 20 |
| Buspirone Hcl | Buspirone Hcl | 82 | 13 |
| Atenolol | Atenolol | 81 | 17 |
| Eliquis | Apixaban | 80 | 12 |
| Ozempic | Semaglutide | 79 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 79 | 20 |
| Metformin Hcl Er | Metformin Hcl | 78 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 78 | 19 |
| Metformin Hcl | Metformin Hcl | 75 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 72 | suppressed |
| Allopurinol | Allopurinol | 70 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 69 | 11 |
| Memantine Hcl | Memantine Hcl | 66 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 62 | 18 |
| Levetiracetam | Levetiracetam | 60 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 60 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 59 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 59 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 56 | 14 |
| Pregabalin | Pregabalin | 56 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | 12 |
| Xarelto | Rivaroxaban | 53 | suppressed |
| Alprazolam | Alprazolam | 51 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 51 | 43 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 50 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 48 | 36 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 45 | 45 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 42 | suppressed |
| Cefdinir | Cefdinir | 41 | 30 |
| Cephalexin | Cephalexin | 41 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 39 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 38 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 36 | 16 |
| Olanzapine | Olanzapine | 36 | suppressed |
| Ezetimibe | Ezetimibe | 35 | 12 |
| Glipizide Er | Glipizide | 35 | suppressed |
| Methocarbamol | Methocarbamol | 35 | 11 |
| Estradiol | Estradiol | 34 | 13 |
| Jardiance | Empagliflozin | 34 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 33 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Mupirocin | Mupirocin | 32 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Torsemide | Torsemide | 31 | suppressed |
| Baclofen | Baclofen | 30 | suppressed |
| Prednisone | Prednisone | 29 | 27 |
| Digoxin | Digoxin | 28 | suppressed |
| Bumetanide | Bumetanide | 26 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 25 | 25 |
| Memantine Hcl Er | Memantine Hcl | 25 | suppressed |
| Mirtazapine | Mirtazapine | 25 | suppressed |
| Telmisartan | Telmisartan | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 23 | suppressed |
| Dutasteride | Dutasteride | 23 | suppressed |
| Gemfibrozil | Gemfibrozil | 23 | suppressed |
| Spironolactone | Spironolactone | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 21 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 21 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 18 |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 18 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Famotidine | Famotidine | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Rybelsus | Semaglutide | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 16 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 16 | 16 |
| Eszopiclone | Eszopiclone | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Minoxidil | Minoxidil | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Restasis Multidose | Cyclosporine | 14 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | 12 |
| Naproxen | Naproxen | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | 11 |
| Glimepiride | Glimepiride | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $34.00 · 1 records | ABBVIE INC. | — | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error